• Master One Thing - Rapamycin Longevity Series

  • By: Krister Kauppi
  • Podcast
Master One Thing - Rapamycin Longevity Series  By  cover art

Master One Thing - Rapamycin Longevity Series

By: Krister Kauppi
  • Summary

  • Rapamycin longevity series is about increasing our knowledge about this longevity compound together with scientists, physicians and other experts.
    Copyright 2024 Venture Plant AB. All rights reserved.
    Show more Show less
Episodes
  • Joan Mannick on Rapamycin Longevity Series | Turning down mTOR to young levels may be good for aging
    Jan 17 2024

    Dr Joan Mannick is one of the world’s leading rapamycin and mTOR researchers in the longevity field. Joan has a background in academic medicine and is currently CEO at her own company Tornado Therapeutics where they focus on developing the next generation of mTOR inhibitors. One of the company goals is to create a mTOR inhibitor which is better than Rapamycin. Throughout the years Joan has made important discoveries in humans when it comes to finding a connection between mTOR inhibition and improvement of the aging immune system. In this podcast we are going to talk about her research, drug development, mTOR, rapamycin, rapalogs and other interesting longevity topics.

    Links

    https://www.tornado-tx.com

    Joan's LinkedIn

    Joan’s research publications

    Big thanks to TimePie for the research help for this episode

    Rapamycin resources

    Rapamycin.news

    Rapamycin Facebook group

    Rapamycin Reddit group

    Connect with Krister on:

    Twitter

    LinkedIn

    Instagram

    Disclaimer: The podcast is for general information and educational purposes only and is not medical advice for you or others. The use of information and materials linked to the podcast is at the users own risk. Always consult your physician with anything you do regarding your health or medical condition.

    Show more Show less
    1 hr and 22 mins
  • Brian Kennedy on Rapamycin Master Series | Aging is the biggest risk factor for age-related diseases
    Oct 17 2023

    Professor Brian Kennedy from the National University of Singapore is one of the world's leading researchers in the longevity field and has done longevity research for more than two decades. He is active in many different longevity companies and has been the President and CEO at Buck Institute for Research on Aging. Throughout the years he has made many different important and revolutionary longevity discoveries. Currently he is also one of the persons who is trying to move the longevity forward in a much efficient and faster way. This work he is doing in Singapore where he is leading a huge longevity research project. This unique project is something we are going to talk about in the podcast. We will also talk about his research on Rapamycin and other interesting longevity topics.

    Links

    The centre for Healthy Longevity at the National University of Singapore

    Healthy Longevity webinars on Youtube

    Brian's research publications

    Brian's Twitter

    Brian's LinkedIn

    Rapamycin resources

    Rapamycin.news

    Rapamycin Facebook group

    Rapamycin Reddit group

    Connect with Krister on:

    Twitter

    LinkedIn

    Instagram

    Disclaimer: The podcast is for general information and educational purposes only and is not medical advice for you or others. The use of information and materials linked to the podcast is at the users own risk. Always consult your physician with anything you do regarding your health or medical condition.

    Show more Show less
    1 hr and 11 mins
  • Mikhail Blagosklonny on Rapamycin Longevity Series | mTOR drives age-related diseases
    Aug 22 2023

    The world's leading Rapamycin researcher Mikhail Blagosklonny has a long background in cancer research and one important discovery he made around 2000 was that Rapamycin slowed down senescent cancer cells in different ways. After that step by step his interest in the longevity field increased and he developed the very interesting hyperfunction theory of aging. He has made a huge contribution in moving the Rapamycin longevity field forward and his research papers have impacted many people. For example, the Rapamycin physician Alan Green who thanks to these papers took the decision in 2017 to start prescribing Rapamycin off label. Today Alan Green has the biggest clinical experience in the area with more than 1200 patients. A lot of other physicians have after that also taken these steps and one of those are for example physician Peter Attia.

    Links

    Mikhail's research publications

    Mikhail's twitter

    Homepage

    Rapamycin resources

    Rapamycin.news

    Rapamycin Facebook group

    Rapamycin Reddit group

    Connect with Krister on:

    Twitter

    LinkedIn

    Instagram

    Disclaimer: The podcast is for general information and educational purposes only and is not medical advice for you or others. The use of information and materials linked to the podcast is at the users own risk. Always consult your physician with anything you do regarding your health or medical condition.

    Show more Show less
    1 hr and 42 mins

What listeners say about Master One Thing - Rapamycin Longevity Series

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.